###begin article-title 0
###xml 25 26 25 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 28 29 28 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 82 89 82 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A4GALT </italic>
###xml 90 91 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 91 92 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 91 92 91 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic></sup>
Two previously proposed P1/P2-differentiating and nine novel polymorphisms at the A4GALT (Pk) locus do not correlate with the presence of the P1 blood group antigen
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 189 191 189 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 262 263 262 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 263 265 263 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
###xml 263 265 263 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k </italic></sup>
###xml 283 284 283 284 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 286 288 286 288 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 375 382 375 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A4GALT </italic>
###xml 383 384 383 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 384 385 384 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 384 385 384 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic></sup>
The molecular genetics of the P blood group system and the absence of P1 antigen in the p phenotype are still enigmatic. One theory proposes that the same gene encodes for both the P1 and Pk glycosyltransferases, but no polymorphisms in the coding region of the Pk gene explain the P1/P2 phenotypes. We investigated the potential regulatory regions up- and downstream of the A4GALT (Pk) gene exons.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 1 3 1 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 17 19 17 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 162 163 162 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 163 165 163 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
###xml 163 165 163 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k </italic></sup>
###xml 195 197 195 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 202 204 202 204 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 321 322 321 322 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 770 772 770 772 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 867 869 867 869 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 904 906 904 906 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 918 920 918 920 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
P1 (n = 18) and P2 (n = 9) samples from donors of mainly Swedish descent were analysed by direct sequencing of PCR-amplified 5'- and 3'-fragments surrounding the Pk coding region. Seventy-eight P1 and P2 samples were investigated with PCR using allele-specific primers (ASP) for two polymorphisms previously proposed as P2-related genetic markers (-551_-550insC, -160A>G). Haplotype analysis of single nucleotide polymorphisms was also performed with PCR-ASP. In ~1.5 kbp of the 3'-untranslated region one new insertion and four new substitutions compared to a GenBank sequence (AL049757) were found. In addition to the polymorphisms at positions -550 and -160, one insertion, two deletions and one substitution were found in ~1.0 kbp of the 5'-upstream region. All 20 P2 samples investigated with PCR-ASP were homozygous for -550insC. However, so were 18 of the 58 P1 samples investigated. Both the 20 P2 and the 18 P1 samples were also homozygous for -160G.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 14 15 14 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 75 77 75 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 149 151 149 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 156 158 156 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 172 173 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 173 175 173 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2 </italic>
###xml 173 175 173 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>2 </italic></sup>
###xml 287 289 287 289 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 372 373 372 373 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 375 377 375 377 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
The proposed P2-specific polymorphisms, -551_-550insC and -160G, found in P2 samples in a Japanese study were found here in homozygous form in both P1 and P2 donors. Since P2 is the null allele in the P blood group system it is difficult to envision how these mutations would cause the P2 phenotype. None of the novel polymorphisms reported in this study correlated with P1/P2 status and the P1/p mystery remains unsolved.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 137 138 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
The P-related blood groups include four antigens that are predominantly of glycolipid nature and occur in related biosynthetic pathways [1].
###end p 9
###begin p 10
###xml 171 173 171 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 230 231 230 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 375 376 375 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k</sup>
###xml 395 396 395 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 450 452 450 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 504 506 504 506 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 560 561 560 561 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 561 563 561 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 608 610 608 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 626 627 626 627 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 627 629 627 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 831 833 831 833 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 858 859 858 859 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1006 1007 1006 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
The GLOB blood group system [International Society of Blood Transfusion (ISBT) number 028] comprises the P antigen and the GLOB collection (ISBT number 209) includes the Pk antigen and also LKE that is not discussed further here [2]. The P1 antigen is assigned to ISBT system number 003. Five phenotypes depending on the presence or absence of the three antigens, P1, P and Pk, are known (Table 1). The presence of all three antigens results in the P1 phenotype but absence of the P1 antigen causes the P2 phenotype. If both P1 and P are absent the phenotype P2k arises. Absence of P but presence of P1 and Pk results in the P1k phenotype. Absence of all three antigens results in the p phenotype. In each of the phenotypes naturally occurring-antibodies can arise against the missing antigen, invariantly so in the case of P and Pk but less frequently for P1. These phenotypes can be explained biochemically by the presence or absence of some of the enzymes shown to catalyse the pathways shown in Figure 1.
###end p 10
###begin p 11
The P/GLOB blood groups.
###end p 11
###begin p 12
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 95 97 95 97 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 102 104 102 104 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
a These frequencies differ significantly between different populations. E.g. the frequency of P1 vs. P2 are virtually the opposite when Caucasians (80 vs. 20%) and Japanese (20 vs 80%) are compared.
###end p 12
###begin p 13
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 117 123 <span type="species:ncbi:9606">people</span>
b While the frequency of this phenotype has been estimated at 1 per million, two population groups, Swedes and Amish people, have significantly higher numbers (e.g. 141 per million in Vasterbotten county in Northern Sweden [21]).
###end p 13
###begin p 14
###xml 46 47 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k</sup>
Biosynthetic pathways relating the P1, P and Pk glycolipids.
###end p 14
###begin p 15
###xml 50 51 50 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 52 53 52 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 72 73 72 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 222 224 222 224 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 304 305 304 305 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 340 341 340 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 476 477 476 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 135 141 <span type="species:ncbi:9606">person</span>
The P1 antigen is present on hematopoietic cells [3,4] and other cells [5]. The strength of the antigen expression can differ from one person to another and it seems to be dependent on gene dosage [1]. Frequencies of the P1 phenotype vary in different ethnic groups, for example, ~80% of Caucasians are P1, compared to only ~20% of Asians [1]. This may be due to selective pressure since P1 and related antigens can act as cellular receptors for microorganisms and biotoxins [5].
###end p 15
###begin p 16
###xml 29 30 29 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k</sup>
###xml 118 119 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 132 133 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 206 207 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 312 313 298 299 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 313 314 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k</sup>
###xml 317 318 303 304 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 318 320 304 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 321 322 307 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 323 324 309 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 333 334 319 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 335 336 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 337 339 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
Two genes that code for the Pk- and P-synthesizing enzymes, 4-alpha-galactosyltransferase (alpha4GalT, Gb3 synthase) [6] and 3-beta-N-acetylgalactosaminyltransferase (beta3GalNAcT, globoside/Gb4 synthase) [7], respectively, have been cloned. Subsequently, numerous mutations have been found to explain the rare P1k, P2k [8,9] and p [6,9-12] phenotypes.
###end p 16
###begin p 17
###xml 313 315 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 470 472 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 742 744 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 841 842 833 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 842 844 834 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 863 864 855 856 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 866 868 858 860 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 880 881 872 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
The molecular genetic background of the P1 antigen remains unknown. Several theories exist, including one model suggesting that the same alpha4GalT is able to transfer galactosyl residues to both lactosylceramide and paragloboside but in order to use the latter as the acceptor, a regulatory protein is required [13]. Another model postulates the existence of two different enzymes, and thus two genes, requiring both of them to be inactivated to cause the p phenotype [13]. A third model proposes a single gene with three alleles, one allele coding for an alpha4GalT that can utilise lactosylceramide and paragloboside as acceptors, one allele using lactosylceramide only and the third allele coding for an inactive form of the transferase [14]. However, none of the known polymorphisms (109A>G, 903G>C, 987G>A) in the coding region of the Pk gene explains the P1/P2 phenotypes [6].
###end p 17
###begin p 18
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 26 28 26 28 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 158 159 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 159 161 159 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
###xml 159 161 159 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k </italic></sup>
###xml 195 196 195 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 198 200 198 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
Recently, Iwamura et al. [15] suggested that transcriptional regulation caused by two polymorphisms (-551_-550insC, -160A>G) in the 5'-upstream region of the Pk gene might be the reason for the P1/P2 phenotypes.
###end p 18
###begin p 19
###xml 4 5 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 5 7 5 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
###xml 5 7 5 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k </italic></sup>
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 392 393 392 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
The Pk gene was originally thought to comprise two exons, but recent GenBank depositions indicate the presence of three exons with the whole coding region in exon 3, as shown in Figure 2. Various publications have considered different transcription starting points resulting in different numbering of the same nucleotide positions. The numbers used here are described in the legend to Figure 2.
###end p 19
###begin p 20
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A4GALT</italic>
###xml 62 63 62 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 63 64 63 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 63 64 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic></sup>
###xml 0 125 0 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Schematic picture of the exon/intron structure of the <italic>A4GALT</italic> (<italic>P</italic><sup><italic>k</italic></sup>) gene and the positions of the 19 polymorphisms investigated</bold>
###xml 245 250 245 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
Schematic picture of the exon/intron structure of the A4GALT (Pk) gene and the positions of the 19 polymorphisms investigated. The numbering systems used are as follows: The 5'-region and exon 1 are described using the same numbering as Iwamura et al. [15] for easy comparison. Intron 1 and exon 2 are numbered from the first nucleotide of each element, with the number being preceded by int1- or ex2-, respectively. The adenosine of the translation start codon ATG in exon 3 is defined as nt. 1. Nucleotides upstream from this (untranslated exon 3 and the 3'-region of intron 2) are given as negative numbers. The exons are represented by rectangles and the intervening introns by triangles. Exons 1-3 are 21, 145 and 1059 bp long, respectively and introns 1 and 2 are approximately 25 and 1.5 kbp long, respectively.
###end p 20
###begin p 21
###xml 93 94 93 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 94 96 94 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
###xml 94 96 94 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k </italic></sup>
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 309 310 309 310 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 312 314 312 314 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
In this study we have investigated an extended sequence surrounding the coding region of the Pk gene including untranslated exons and intronic portions as well as potentially regulatory regions 5' or 3'of the transcribed region. Contrary to a previous report [15], we found no clear-cut correlation with the P1/P2 phenotype, neither between previously described polymorphisms in the 5'-regulatory region, nor any of the novel polymorphisms reported in this study.
###end p 21
###begin title 22
Results
###end title 22
###begin title 23
Screening for the -551_-550insC and -160A>G polymorphisms by PCR-ASP
###end title 23
###begin p 24
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 104 106 104 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 390 392 390 392 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 511 512 511 512 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 558 560 558 560 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 654 656 654 656 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 772 773 772 773 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1211 1212 1211 1212 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1212 1214 1212 1214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 1224 1225 1224 1225 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1225 1227 1225 1227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 1277 1278 1277 1278 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1278 1280 1278 1280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 1363 1365 1363 1365 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1421 1422 1421 1422 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1422 1424 1422 1424 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 1505 1506 1505 1506 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1506 1508 1506 1508 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
Seventy-eight samples were screened for the two genetic markers previously [15] suggested to cause the P2 phenotype. The results are summarized in Table 2. Two haplotypes, -550T;-160A and -551_-550insC;-160G, were found whilst the other theoretically possible haplotypes, 550T;-160G and -551_-550insC;-160A, were not detected in this study. Each of the 20 samples, that were phenotyped as P2 were homozygous for both -551_-550insC and -160A>G, which could indicate that these polymorphic positions were indeed P2-specific as proposed. However, 18 of the 58 P1 samples investigated were also homozygous for the same polymorphic markers. Of the remaining P1 samples, 32 were heterozygous at both nucleotide positions and only eight samples were homozygous for the proposed P1-specific combination, -550T;-160A. Twenty-nine of the 32 heterozygous samples were available for analysis by two haplotype-specific PCR reactions (-550T;-160A and -551_-550insC;-160G). All samples were positive in both PCR reactions, indicating that the samples were heterozygous for the combinations -550T;-160A and -551_-550insC;-160G and not for -550T;-160G and -551_-550insC;-160A. Additionally, 26 samples with the rare phenotypes P1k (n = 3), P2k (n = 3) and p (n = 20) were screened. One of the P1k samples was homozygous for the genetic markers reported to be associated with the P2 phenotype, and the other two were heterozygous. Of the P2k samples two had the expected polymorphisms (-551_-550insC;-160G), but the third P2k was heterozygous and thus the first reported sample that lacks the P1 antigen in spite of a genotype not homozygous for the -551_-550insC and -160G markers. Sixteen of the 20 p samples were homozygous for -551_-550insC;-160G, thus consistent with their lack of P1, but one was heterozygous and three were homozygous for -550T;160A. Due to lack of available DNA from these rare individuals the haplotype-specific PCR was only run on one of the four heterozygous samples. As above, this sample was also positive in both PCR reactions.
###end p 24
###begin p 25
The occurrence of the -550T;-160A and -551_-550insC;-160G haplotypes in individuals with various P phenotypes.
###end p 25
###begin title 26
###xml 57 59 57 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P<sup>k </sup></italic>
Amplification of the 5'-, 3'- and coding regions of the Pk gene for DNA sequencing
###end title 26
###begin p 27
###xml 15 17 15 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 31 32 31 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 184 185 184 185 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 219 221 219 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 276 277 276 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 277 279 277 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
###xml 277 279 277 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k </italic></sup>
Ten of the 18 P1 samples with P2-associated polymorphisms (-551_-550insC;-160G) were chosen for further investigation by sequencing the 5'-region and the 3'-region, as were all eight P1(-550T;-160A) and nine of the 20 P2 samples. In three samples from each category the whole Pk gene reading frame, located in exon 3, was also sequenced.
###end p 27
###begin p 28
In the 5'-region upstream of exon 1, four novel polymorphisms were detected compared to a sequence deposited in GenBank (accession number AL049757). These findings comprised a substitution (-770C>T), an insertion (-107_-106insG) and two deletions (-907_-903del and -17_8del). Interestingly, the latter deletion is located across the border of the 5'-region and exon 1.
###end p 28
###begin p 29
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
In the 3'-UTR, five new polymorphisms were found, four of which were substitutions (1409G>A, 1495C>A, 1523G>A, 1697G>A) and one was an insertion (1592dupG). Figure 2 shows the relative positions of the polymorphisms investigated.
###end p 29
###begin p 30
###xml 141 142 141 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 224 226 224 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
The distribution of the polymorphisms in the three different categories, P1(-550T;-160A), P1(-551_-550insC;-160G) and P2 are shown in Figure 3. As can be seen, none of the polymorphisms is a genetic marker specific for the P2 phenotype. On the other hand, individuals from the P1(-550T;-160A) category are homozygous for 12 of the 16 investigated polymorphisms. However, when individuals from the P1(-551_-550insC;-160G) samples are included such pattern is no longer evident. It can also be noted that the frequency of some of the variants appears to be relatively low, less than ~10 %, for six of the polymorphic sites analyzed.
###end p 30
###begin p 31
###xml 0 134 0 134 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The distribution of the polymorphic variants in the three different sample categories: P1(-550T;-160A), P1(-551_-550insC;-160G) and P2</bold>
The distribution of the polymorphic variants in the three different sample categories: P1(-550T;-160A), P1(-551_-550insC;-160G) and P2. The diagram shows data of 16 polymorphisms investigated. The data for the 5'- and the 3'-regions were obtained by sequencing while most of the data for exon 3 originated from PCR-ASP analysis. Eight, P1(-550T;-160A), ten P1(-551_-550insC;-160G) and nine P2 samples were investigated. However, for the 903C>G polymorphism the corresponding numbers were five, five and seven samples. In position -107_-106 all investigated samples had three guanosines instead of two as reported in the reference sequence (AL049757). We therefore do not consider this position as polymorphic in our analysis and it is consequently not included in this figure. cons. = consensus.
###end p 31
###begin p 32
While sequencing exon 3, an unexpected mutation, 441G>A, was encountered in a P1 sample of African origin. No other samples, including two of African descent, examined in this study had this particular mutation, which would not alter the amino acid sequence, or any other new polymorphisms.
###end p 32
###begin title 33
Haplotype analysis of SNPs in the reading frame and a polymorphism in the 3'-UTR using PCR-ASP
###end title 33
###begin p 34
###xml 85 86 85 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 86 88 86 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
###xml 86 88 86 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k </italic></sup>
###xml 110 120 110 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis/trans </italic>
###xml 522 523 522 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 574 575 574 575 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 577 579 577 579 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
We also performed PCR-ASP utilising polymorphisms in exon 3 and in the 3'-UTR of the Pk gene to determine the cis/trans linkage of SNPs and to establish if combinations of polymorphisms correlated with specific alleles. The SNPs chosen were two of those previously described, i.e. 109A>G and 987G>A. Analysis of the polymorphism 903C>G was considered unnecessary due to its proximity to nt. 987. In addition, of the new polymorphisms the one furthest downstream (1697G>A) was analyzed. The results are summarized in Table 3. None of the haplotypes correlated well with the P1/P2 phenotypes although 83% of the alleles among the P2 samples and 75% of the P1(-551_-550insC;-160G) category samples had the A-1 haplotype, whilst in the P1(-550T;-160A) category samples only 12.5% had this partial haplotype (B-1). The remaining alleles in this latter category consisted of 12.5% of the rare B-3 and 75% of the B-2 haplotype.
###end p 34
###begin p 35
Correlation of phenotype and haplotype
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 345 347 337 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 458 460 450 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 465 466 457 458 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 466 468 458 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 607 609 595 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 833 834 821 822 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 836 838 824 826 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 880 882 868 870 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1158 1159 1146 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1207 1214 1195 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A4GALT </italic>
The molecular background of the P blood group system has been a subject of speculation since its discovery. Antigens formed as a result of closely related biosynthetic pathways are now known to arise from independent genetic loci. However, the current paradox revolves around the 4-alpha-galactosyltransferase (alpha4GalT) that synthesises the Pk antigen and possibly also the P1 antigen. If it is indeed exactly the same enzyme synthesizing both, then the P2 and P2k phenotypes should not exist, as the P1-synthesizing alpha4GalT that is lacking in these individuals should also result in the loss of the Pk and, subsequently, P antigens. The absence of the P1 antigen is not due to a defect in the biosynthesis of paragloboside since this glycolipid is a major precursor of the erythrocyte ABH antigens that are unaffected by the P1/P2 status. The absence of P1 antigen in the P2 phenotype is likely to be caused by inefficient or absent glycosyltransferase activity that can be due to a structural defect in the enzyme itself or more indirectly due to various other factors necessary to ensure the enzyme's optimal expression, localisation and efficiency[1]. Studies are currently in progress to analyse A4GALT mRNA by real-time PCR and other methods.
###end p 37
###begin p 38
###xml 12 14 12 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 257 263 257 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 319 321 319 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 819 824 819 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 942 944 942 944 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
The P1 and Pk antigens both share the same terminal carbohydrate structure and therefore the question arises whether the same enzyme is, or is not, synthesizing both antigens. Various theories exist but so far none has been proven correct. Recently Iwamura et al [15] proposed that the P1 synthase is identical to the Pk synthase and that the phenotypic difference may be caused by two polymorphisms, -160A>G and -551_-550insC, found in the 5'-upstream regulatory region. Unfortunately, these authors were not able to show any functional effects of these two polymorphisms, at least not when tested in a fibroblast cell line. As they commented themselves, a haematopoietic cell line, preferentially even an erythropoietic one, would have been the optimal choice for the challenge but was technically difficult. Iwamura et al. also demonstrated the presence of cryptic and intracellular P1 antigen in cells from individuals known to have the P2 red blood cell phenotype. Whether this surprising finding is method-dependent or may differ between populations is currently unclear.
###end p 38
###begin p 39
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 201 202 201 202 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 202 203 202 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k</sup>
###xml 223 225 223 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 303 305 303 305 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 331 336 331 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 395 402 395 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A4GALT </italic>
###xml 477 478 477 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 675 682 675 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A4GALT </italic>
###xml 894 895 894 895 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 895 897 895 897 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 902 903 902 903 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 903 905 903 905 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 917 918 917 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 919 920 919 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 963 970 963 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A4GALT </italic>
###xml 1267 1268 1267 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
Our data indicate that an individual's P1/P2 status is not due to the -551_-550insC;-160G haplotype, contrary to the previously published indication [15]. However, it is striking that all (except one P2k) samples with the P2 phenotype tested here have the same -551_-550insC;-160G haplotype as all ten P2 samples tested by Iwamura et al. This clearly argues that the genetic linkage between the A4GALT locus and P2 status must be relatively strong. The results shown in Figure 3 indicate that none of the 16 polymorphic markers investigated can predict the serologically determined P1/P2 status. It is also interesting to note the high frequency with which SNPs occur in the A4GALT gene, as opposed to the gene coding for the next glycosyltransferase in this biosynthetic pathway, the P synthase, in which we have found no variations at all. The only exceptions are rare mutations causing the P1k and P2k phenotypes [8,9]. Despite the apparent variability in the A4GALT gene, the current study suggests that a limited number of haplotypes, with the A-1 and B-2 haplotypes being the predominant ones in the Swedish population, may constitute genetic clusters within which further variation has arisen (as judged by the lack of homogeneity within each group, see Table 3), still without obvious correlation to the blood group phenotype.
###end p 39
###begin p 40
###xml 321 328 317 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">either </italic>
###xml 393 394 389 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k</sup>
###xml 453 455 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 458 461 450 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">or </italic>
###xml 632 634 620 622 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 647 649 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 792 794 780 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
However, all this does not differentiate between the one-gene theory and the possibility of a tightly coupled independent locus responsible for P1 antigen expression. Since there are no apparent alpha4GalT homologues in this genetic region this may imply that a hypothetical second closely linked gene would give rise to either a regulatory molecule modifying the acceptor specificity of the Pk-synthesizing alpha4GalT (analogous to lactose synthetase [16]) or a chaperone type of molecule to make a fraction of the alpha4GalT molecules more suitably located/positioned for P1 synthesis. The finding of intracellular P1 antigen in P2 individuals [15], would tend to support the latter possibility. Chaperones have been shown to be involved in processes related to glycosyltransferase action [17] but it is somewhat difficult (although not impossible) to imagine an alpha4GalT-specific chaperone to be the solution for this long-standing enigma.
###end p 40
###begin title 41
Conclusion
###end title 41
###begin p 42
###xml 58 59 58 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 59 61 59 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
###xml 59 61 59 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k </italic></sup>
###xml 165 166 165 166 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 168 170 168 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 266 268 266 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 346 348 346 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 385 387 385 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 499 501 499 501 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
The study of potential regulatory regions surrounding the Pk coding sequence revealed nine previously unreported polymorphisms but none of them correlated with the P1/P2 red blood cell phenotypes. Two polymorphisms, -551_-550insC and-160A>G, suggested to cause the P2 phenotype in Japanese individuals [15] were found in homozygous form also in P1 samples in this study and since the P2 is the null phenotype of this blood group system, it is therefore very unlikely that these mutations cause the P2 phenotype.
###end p 42
###begin title 43
Methods
###end title 43
###begin title 44
Blood samples and DNA preparation
###end title 44
###begin p 45
###xml 18 20 18 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 34 36 34 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 213 214 213 214 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 214 215 214 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k</sup>
###xml 224 225 224 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 225 227 225 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 333 334 333 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 335 336 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
Samples with the P1 (n = 58) and P2 (n = 20) phenotypes were chosen from our in-house panel of test erythrocytes. The majority of the donors are of Swedish origin but a few are of Asian or African descent. Three P1k, three P2k and 20 p samples, genetically characterized in our laboratory, were also included for screening purposes [8,9,12,18]. The erythrocyte phenotype was determined by standard serological techniques.
###end p 45
###begin p 46
###xml 106 111 106 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 214 215 214 215 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
DNA was prepared from EDTA blood using a simple salting-out method for small volumes modified from Miller et al. [19], or Qiagen QIAmp Blood Extraction kit (Qiagen GmbH, Hilden, Germany). The DNA was dissolved in H2O at a concentration of 100 ng/mul.
###end p 46
###begin title 47
Screening for the -551_-550insC and -160A>G polymorphisms by PCR-ASP
###end title 47
###begin p 48
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 267 269 267 269 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 497 498 497 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 716 717 716 717 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 897 898 896 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
All oligonucleotide primers used in the study were synthesized by DNA Technology ApS (Aarhus, Denmark) and the sequences are shown in Table 4. PCR with allele-specific primers designed to detect the polymorphisms at -551_-550insC and -160A>T, described to cause the P2 phenotype [15] was performed. For all heterozygous samples double allele-specific amplification, -551_-550insC;-160G and -550T;160A, were performed. The primer combinations used are listed in Table 5 and the locations in Figure 4. Primers were mixed with 100 ng of genomic DNA, 2 nmol of each dNTP, 2% glycerol, 1% cresol red and 0.5 U of AmpliTaq Gold (Perkin Elmer/Roche Molecular Systems, Branchburg, NJ, USA) in 10 x PCR buffer with 15 mM MgCl2. The final reaction volume was 11 mul. Thermocycling was undertaken in GeneAmp PCR system 2400/2700 (Perkin-Elmer/Cetus, Norwalk, CT, USA) under PCR conditions described in Table 5.
###end p 48
###begin p 49
Oligonucleotide primers used in this study.
###end p 49
###begin p 50
###xml 0 7 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8224; </sup>
dagger F = Forward. R = Reverse. The underlined nucleotide is mismatched for better specificity.
###end p 50
###begin p 51
a. used for amplification of the 5' regulatory region.
###end p 51
###begin p 52
b. used for sequencing of the 5' regulatory region.
###end p 52
###begin p 53
c. used for amplification of the 3'-UTR.
###end p 53
###begin p 54
d. used for sequencing the 3'-UTR.
###end p 54
###begin p 55
e. used for PCR-ASP.
###end p 55
###begin p 56
f. used as internal control.
###end p 56
###begin p 57
Oligonucleotide primer combinations and PCR conditions (previously not described) used for PCR-ASP in this study.
###end p 57
###begin p 58
Denaturation was carried out at 96degreesC for 7 min followed by 35 cycles at 94degreesC for 30 s. The annealing time was 30 s.
###end p 58
###begin p 59
* Four double allele-specific amplifications were performed.
###end p 59
###begin p 60
** These combinations were used for allele-specific amplifications for sequencing purposes.
###end p 60
###begin p 61
###xml 129 131 129 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 0 142 0 142 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Schematic representation of the primers used to identify the polymorphisms at -551_-550insC and -160A&gt;T, described to cause the P<sub>2 </sub>phenotype. </bold>
Schematic representation of the primers used to identify the polymorphisms at -551_-550insC and -160A>T, described to cause the P2 phenotype. The figure also shows combinations and positions for the primers used to detect a linkage phase of SNPs in the reading frame with a polymorphism in the 3'-UTR. For size reference, see Figure 2.
###end p 61
###begin title 62
###xml 57 59 57 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">k </sup>
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P<sup>k </sup></italic>
Amplification of the 5'-, 3'- and coding regions of the Pk gene for DNA sequencing
###end title 62
###begin p 63
###xml 34 35 34 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 35 37 35 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
###xml 35 37 35 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k </italic></sup>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
The coding region, exon 3, in the Pk gene was amplified with the primer pair Pk-(-140)-F and Pk-1120-R in the Expand High Fidelity PCR System (Roche Molecular Systems, Pleasanton, CA, USA) and sequenced as previously described [12].
###end p 63
###begin p 64
###xml 32 33 32 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 33 35 33 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k </italic></sup>
###xml 370 372 369 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
The 5'-regulatory region of the Pk gene was amplified with primers Pk-5'-(-1056)-F and Pk-int1-160-R and Pk-5'-(-131)-F and Pk-int1-160-R. Amplification was performed in a reaction volume of 22 muL with four pmol of each primer, 2 nmol of each dNTP, 100 ng of genomic DNA, GC-rich enzyme mix (0.5 U per reaction), GC-rich resolution solution and buffer with a final MgCl2 concentration of 1.5 mM (GC-rich PCR System, Roche Diagnostics GmbH, Mannheim, Germany). Thermocycling was undertaken in GeneAmp PCR system 2400/2700 (Perkin-Elmer/Cetus): Initial denaturation at 96degreesC for 7 min followed by 10 cycles at 94degreesC for 30 s, 62degreesC for 30 s and 72degreesC for 1 min and then 25 cycles at 94degreesC for 30 s, 60degreesC for 30 s and 72degreesC for 1 min.
###end p 64
###begin p 65
###xml 25 26 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 26 28 26 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
###xml 26 28 26 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k </italic></sup>
###xml 266 267 266 267 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
For the 3'-region of the Pk gene 5 pmol of primers Pk-(1006)-F and Pk-(1881)-R were mixed with 100 ng of genomic DNA, 2 nmol of each dNTP, 2% glycerol, 1% cresol red and 0.5 U of AmpliTaq Gold (Perkin Elmer/Roche Molecular Systems) in 10 x PCR buffer with 15 mM MgCl2. The final reaction volume was 11 mul. PCR was run at 96degreesC for 7 min followed by 35 cycles at 94degreesC for 30 s, 64degreesC for 30 s and 72degreesC for 1 min.
###end p 65
###begin p 66
###xml 658 659 658 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
PCR products were excised from 3% agarose gels (Seakem, FMC Bioproducts, Rockland, ME, USA) stained with ethidium bromide (0.56 mg/l gel, Sigma Chemicals, St. Louis, MO, USA) following high-voltage electrophoresis and purified using Qiaquick gel extraction kit (Qiagen). The Big Dye Terminator Cycle Sequencing kit (Applied Biosystems, Foster City, CA, USA) and an ABI PRISM 310 Genetic Analyser (Applied Biosystems) were used for direct DNA sequencing with capillary electrophoresis and automated fluorescence-based detection according to the manufacturer's instructions. Besides the PCR primers, internal primers were used as sequencing primers, see Table 4. To avoid detection of artefacts, sequencing was performed on both strands and using independently obtained fragments.
###end p 66
###begin title 67
Detection of an insertion in exon 2 and linkage of SNPs in the reading frame with a polymorphism in the 3'-UTR using PCR-ASP
###end title 67
###begin p 68
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 457 458 457 458 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 561 562 560 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 573 574 572 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
PCR-ASP for a previously found insertion, 75dupC in exon 2 (then believed to be exon 1), was also performed as described [12]. PCR-ASP was performed to investigate if the polymorphisms at nt. 109, 987 and 1697 were present in an allele-specific pattern. The reaction mixtures comprised 100 ng of genomic DNA, 2 nmol of each dNTP, 2% glycerol, 1% cresol red and 0.5 U of AmpliTaq Gold (Perkin Elmer/Roche Molecular Systems) in 10 x PCR buffer with 15 mM MgCl2. The final reaction volume was 11 mul. Primer combinations and PCR conditions are described in Figure 4 and Table 5.
###end p 68
###begin title 69
List of abbreviations
###end title 69
###begin p 70
ASP, allele specific primer
###end p 70
###begin p 71
bp, base pairs
###end p 71
###begin p 72
ins, insertion
###end p 72
###begin p 73
del, deletion
###end p 73
###begin p 74
kb, kilo bases
###end p 74
###begin p 75
PCR, polymerase chain reaction
###end p 75
###begin p 76
SNP, single nucleotide polymorphism
###end p 76
###begin p 77
UTR, untranslated region
###end p 77
###begin p 78
ISBT, International Society of Blood Transfusion.
###end p 78
###begin title 79
Authors' contributions
###end title 79
###begin p 80
AH carried out the experimental studies and participated in the discussion and preparation of the manuscript. AC participated in the discussion and preparation of the manuscript. MLO contributed to the design and coordination of the study and participated in preparation of the manuscript. All authors read and approved the final manuscript.
###end p 80
###begin title 81
Acknowledgements
###end title 81
###begin p 82
Sources of support: This work was supported in part by the Swedish Research Council (project no. K2005-71X-14251), the Medical Faculty at Lund University, governmental ALF research grants to Lund University Hospital, the Inga & John Main Foundation for Medical Research and the Lund University Hospital Donation Funds.
###end p 82
###begin p 83
###xml 74 77 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
Part of this study has previously been reported in abstract form at the 28th Congress of the International Society of Blood Transfusion held in Edinburgh, UK, on 11-15 July 2004 [20].
###end p 83
###begin article-title 84
Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens
###end article-title 84
###begin article-title 85
Status of major red cell blood group antigens on neutrophils, lymphocytes and monocytes
###end article-title 85
###begin article-title 86
###xml 38 43 <span type="species:ncbi:9606">human</span>
Presence of P blood group antigens on human platelets
###end article-title 86
###begin article-title 87
The P blood group system: biochemical, serological, and clinical aspects
###end article-title 87
###begin article-title 88
Cloning and expression of the histo-blood group Pk UDP-galactose: Gal-beta1-4Glc-beta1-Cer alpha1,4-galactosyltransferase. Molecular genetic basis of the p phenotype
###end article-title 88
###begin article-title 89
###xml 22 27 <span type="species:ncbi:9606">human</span>
Expression cloning of human globoside synthase cDNAs. Identification of beta3Gal-T3 as UDP-N-acetylgalactosamine:globotriaosylceramide beta1,3-N-acetylgalactosaminyltransferase
###end article-title 89
###begin article-title 90
Molecular basis of the globoside-deficient Pk blood group phenotype. Identification of four inactivating mutations in the UDP-N- acetylgalactosamine:globotriaosylceramide 3-beta-N-acetylgalactosaminyltransferase gene
###end article-title 90
###begin article-title 91
Genetic heterogeneity at the glycosyltransferase loci underlying the GLOB blood group system and collection
###end article-title 91
###begin article-title 92
Molecular basis for the p phenotype. Identification of distinct and multiple mutations in the alpha1,4-galactosyltransferase gene in Swedish and Japanese individuals
###end article-title 92
###begin article-title 93
Three-base deletion and one-base insertion of the alpha(1,4)galactosyltransferase gene responsible for the p phenotype
###end article-title 93
###begin article-title 94
Additional molecular bases of the clinically important p blood group phenotype
###end article-title 94
###begin article-title 95
###xml 31 36 <span type="species:ncbi:9606">human</span>
An immunochemical study of the human blood group P1, P, and PK glycosphingolipid antigens
###end article-title 95
###begin article-title 96
A genetic model for the inheritance of the P, P1 and Pk antigens
###end article-title 96
###begin article-title 97
The blood group P1 synthase gene is identical to the Gb3/CD77 synthase gene. A clue to the solution of the P1/P2/p puzzle
###end article-title 97
###begin article-title 98
Lactose synthetase
###end article-title 98
###begin article-title 99
A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase
###end article-title 99
###begin article-title 100
A novel missense mutation in the A4GALT gene of Amish individuals with the p phenotype.
###end article-title 100
###begin article-title 101
###xml 55 60 <span type="species:ncbi:9606">human</span>
A simple salting out procedure for extracting DNA from human nucleated cells
###end article-title 101
###begin article-title 102
Sixteen polymorphic sites in the 5 /3 -UTR of the Pk gene do not correlate with P1/P2 phenotypes
###end article-title 102
###begin article-title 103
Population studies in northern Sweden. IV. Frequency of the blood type p
###end article-title 103

